In our study, m6A-seq and RNA-seq revealed that FEN1 was the downstream gene of IGF2BP2 and confirmed the oncogenic effect of FEN1 and revealed an m6A-dependent regulatory mechanism to partially explain the common upregulation of FEN1 in cancer. Here, IGF2BP2 is linked to cancer.